The 20 Best Cystic Fibrosis Doctors Near Me in Baltimore, MD

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Elite provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Dr. Lechtzin is a pulmonary and critical care medicine physician. He directs the Adult CF program and the neuromuscular pulmonary clinic at Johns Hopkins and is an expert in the treatment of cystic fibrosis, pulmonary complications of neuromuscular disease and the care of critically ill patients in the Medical ICU. He is a member of the Longcope Firm Faculty and provides teaching to medical students and residents at Johns Hopkins. Dr. Lechtzin is rated as an Elite provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy. Dr. Lechtzin is board certified in American Board Of Internal Medicine.

Albert Faro is a Pediatric Pulmonologist practicing medicine in Nottingham, Maryland. Dr. Faro is rated as an Elite provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Cerebral Hypoxia, Gastroesophageal Reflux Disease (GERD), and Lung Transplant.

Dr. Rebecca Dezube is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are cystic fibrosis and critical care medicine. She sees patients in the adult cystic fibrosis (CF) clinic as well as in the medical intensive care unit (MICU). She received her A.B. from Harvard University and earned her M.D. from Vanderbilt University School of Medicine. She completed her residency in internal medicine at Johns Hopkins, where she also served as an Assistant Chief of Service. She also trained as a fellow in pulmonary and critical care medicine at Johns Hopkins and served as the Chief Fellow in Pulmonary and Critical Care Medicine. Dr. Dezube joined the Johns Hopkins faculty in 2017. Dr. Dezube is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), and Newborn Jaundice. Dr. Dezube is board certified in American Board Of Internal Medicine.

Dr. Kristina Montemayor is an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Johns Hopkins. She worked as a bedside nurse for five years prior to receiving her medical degree with honors from the University of Texas Medical Branch and then completed her Internal Medicine residency and Pulmonary and Critical Care fellowship training at Johns Hopkins. Her clinical and research areas of expertise include adult cystic fibrosis, sex differences in pulmonary exacerbations, and women's health in cystic fibrosis. Her clinical work also involves caring for critically ill patients in Intensive Care Units. Dr. Montemayor joined the faculty in 2020 and has also been involved with undergraduate and graduate medical education. At the UME level, she is the Course Director for the pulmonary section of the pre-clerkship courses. At the GME level, she is Firm Faculty Leader of the Longcope Firm and Senior Associate Program Director of the Osler Medical Residency. In July 2024, she became the Director of the Fellowship Training Program in Pulmonary and Critical Care Medicine. Dr. Montemayor is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Bronchiectasis. Dr. Montemayor is board certified in American Board Of Internal Medicine.

Dr. J. Michael Collaco is a professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical specialty is pediatric pulmonary medicine, including chronic lung disease of premature infants, lung disease in medically complex patients including ventilators and tracheostomies, hereditary hemorrhagic telangiectasia, aerodigestive disorders, and general pediatric pulmonary conditions. He sees patients inpatient and outpatient at Johns Hopkins (East Baltimore campus), inpatient and outpatient at Mount Washington Pediatric Hospital, and inpatient at Kennedy Krieger Institute. Dr. Collaco attended Yale University for undergraduate studies and received his M.D. and M.S. (Anatomy) from Case Western University School of Medicine in Cleveland, Ohio. He completed his pediatric residency, pediatric pulmonary fellowship, M.B.A., M.P.H., and Ph.D. (Clinical Epidemiology) at the Johns Hopkins University. Dr. Collaco joined the Johns Hopkins faculty in 2008. His primary research interest is in the epidemiology of pediatric respiratory diseases, with a focus on environmental risk factors for cystic fibrosis and bronchopulmonary dysplasia as well as a special interest in the effects of secondhand smoke and electronic cigarette emissions. He has published over 140 peer-reviewed articles. Dr. Collaco is a member of the Cystic Fibrosis Research Development Center and the Hereditary Hemorrhagic Telangiectasia Center of Excellence. He has been recognized by Johns Hopkins with the John C. Hume Scholarship, the Francis F. Schwentker Research Award, and the Robert Dyar Award. Dr. Collaco is a fellow of the American Academy of Pediatrics. Dr. Collaco is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Cystic Fibrosis, Pulmonary Hypertension, Pseudomonas Stutzeri Infections, and Gastrostomy. Dr. Collaco is board certified in American Board Of Pediatrics.

Dr. Shruti Paranjape attended the University of Pennsylvania and received her M.D. from the University of Pittsburgh. She completed her pediatrics residency and pediatric pulmonology fellowship at Children’s Hospital of Pittsburgh. She has served as the Assistant Director of the CF Center at Children’s Hospital of Pittsburgh. Her awards include the James Sutherland Award for Outstanding Research by a Young Investigator. Dr. Paranjape is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Jaundice. Dr. Paranjape is board certified in American Board Of Pediatrics.

Patrick Sosnay is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Sosnay is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Lung Metastases.

Michael Noto is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Noto is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Pneumomediastinum.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Dr. Natalie West is a pulmonary specialist in the Greater Baltimore area who specializes in the diagnosis and treatment of cystic fibrosis. Her focus also includes the treatment of interstitial lung disease, lung transplantation, COPD, asthma, and pulmonary hypertension. She also manages patients in the medical intensive care unit with acute respiratory failure caused by asthma, pneumonia, COPD, and the acute respiratory distress syndrome, as well as other conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis, and shock from sepsis, hypovolemia, and heart disease. Dr. West also serves as the associate program director of the Johns Hopkins Pulmonary and Critical Care Fellowship Program and plays an active role in recruitment of new fellows and mentoring fellows in the division. Dr. West is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Pulmonary Aspergilloma.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine.

Dr. Fessler is a specialist in Pulmonary and Critical Care Medicine. He is an expert in the diagnosis and management of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and shock. Dr. Fessler is rated as an Advanced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Cystic Fibrosis, Acute Interstitial Pneumonia, and Interstitial Lung Disease. Dr. Fessler is board certified in American Board Of Internal Medicine.

Lori Vanscoy is a Pediatric Pulmonologist practicing medicine in Baltimore, Maryland. Dr. Vanscoy is rated as an Advanced provider by MediFind in the treatment of Cystic Fibrosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Jaundice. Dr. Vanscoy is board certified in American Board Of Pediatrics.

Bruce Marshall is a primary care provider, practicing in Pulmonary Medicine in Baltimore, Maryland. Dr. Marshall is rated as a Distinguished provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Lung Transplant.

Muhammad Qureshi is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Qureshi is rated as an Advanced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.

Roy Brower is a Professor of Medicine at Johns Hopkins University and was Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital for over 30 years. He obtained his M.D. degree and completed his residency and fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins. Brower’s earlier research explored mechanisms of cardiopulmonary interactions and pulmonary circulation physiology. He subsequently focused research efforts in the clinical venue. Brower has led four multicenter clinical trials of lung-protective mechanical ventilation strategies in patients with the acute respiratory distress syndrome (ARDS). One of these trials demonstrated substantially improved clinical outcomes in ARDS patients who received mechanical ventilation with lower tidal volumes. Brower was a member of the NIH ARDS Network from its inception in 1994. He was the Chair of the Steering Committee of the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Network from 2014 to 2023. Brower has been actively involved in the American Thoracic Society. He served on the Program Committee of the Pulmonary Circulation Assembly and chaired the ATS Critical Care Assembly Planning Committee for two years. He served as chair of the Critical Care Assembly from 2003-2005 and is the recipient of the Critical Care Lifetime Achievement Award. Brower chaired the ATS Publications Policy Committee from 2012 to 2016 and twice received the ATS Presidential Citation. Brower is an accomplished clinical educator. The Johns Hopkins Osler Medical Residency Program awarded him its annual award for outstanding teaching twice, in 1996 and in 2015. The Johns Hopkins Pulmonary and Critical Care Medicine Fellowship program awarded him its annual Fellows Teaching Award in 2009. As the former Medical Director of the Medical Intensive Care Unit at Johns Hopkins Hospital, Brower focused the energy of the critical care staff to develop rigorous, evidence-based protocols and practice guidelines. He promotes standardization of care with good protocols because they help to reduce medical errors, improve the clinical research environment, and serve as effective teaching tools. Dr. Brower is rated as an Experienced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy. Dr. Brower is board certified in American Board Of Internal Medicine.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is rated as an Experienced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Experienced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy. Dr. Buescher is board certified in American Board Of Internal Medicine.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Cystic Fibrosis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.